FDA Approves Genentech’s Avastin® (Bevacizumab) Plus Chemotherapy as a Treatment for Women with Advanced Ovarian Cancer Following Initial Surgery

Avastin is now approved for ten distinct uses across six different types of cancer in the United States.

SOUTH SAN FRANCISCO, Calif. – June 13, 2018 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Avastin® (bevacizumab) in combination with chemotherapy (carboplatin and paclitaxel), followed by Avastin as a single agent, for the treatment of women with advanced (stage III or IV) ovarian cancer following initial surgical resection.

May 8 is World Ovarian Cancer Day!

On May 8, people around the world are gathering to support awareness of ovarian cancer. Join SHARE by following us on Facebook, Twitter, and Instagram, where we’ll be posting about signs, symptoms, and stories you can share with the women in your life.

SHARE’s Annual Volunteer Party

April is National Volunteer Appreciation Month, and SHARE hosted its annual volunteer party to show how much we appreciate the incredible commitment of our volunteers. It was another great gathering with a raffle, food, music, and of course, amazing company.

Supporters Gather at Tiro A Segno

Recently SHARE was joined by a circle of its friends and supporters at the historic Italian heritage club Tiro A Segno for an evening of food, drink, and learning about SHARE’s impact on women in the New York City area and beyond.

Announcing SHARE’s National Expansion

New Support Groups Active in Norwalk, CT; Brentwood, NY; and Orlando, FL
After 42 years in New York City, SHARE Cancer Support has announced a national expansion effort. Norwalk, CT; Brentwood, Long Island, NY; and Orlando, FL are the first cities outside New York City to offer SHARE’s in-person services to women with breast or ovarian cancers.

Introducing new program formats

If you receive our program calendar or email newsletter, you may have noticed some new types of educational programs. In addition to our webinars and in-person programs, we are now offering interactive educational opportunities through other platforms. These new kinds of programs offer the same quality content, and make it easy for you to engage with the presenters.

National Helpline:
844-ASK-SHARE